Late-onset NPM1 Mutation in a MYC-amplified Relapsed/refractory Acute Myeloid Leukemia Patient Treated with Gemtuzumab Ozogamicin and Glasdegib.Sonia Jaramillo,Michael Scherer,Chelsea Szu-Tu,Sergi Beneyto-Calabuig,Carsten Müller-Tidow,Richard F. Schlenk,Michael Hundemer,Lars Velten,Caroline PabstHaematologica(2024)引用 0|浏览8AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要